Morgan Stanley vs Novartis AG
Morgan Stanley is worth $336.227B, 1.1× the $299.439B market cap of Novartis AG. Updated daily.
| Metric | Novartis AGNVS  | |
|---|---|---|
| Market cap | $336.227B | $299.439B |
| Global rank | #1 | #2 |
| Share price | $214.08 | $157.54 |
| Change | -0.46% | +1.90% |
| Revenue | $65.966B | $56.674B |
| Net income | $16.861B | $13.984B |
| Country | United States | Switzerland |
| Sector | Financial Services | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Morgan Stanley bigger than Novartis AG?
- Morgan Stanley has a market cap of $336.227B against $299.439B for Novartis AG, making it 1.1 times as valuable.
- Which company earns more, MS or NVS?
- Morgan Stanley reported net income of $16.861B and Novartis AG reported $13.984B in their most recent annual periods.